FDA approves first gene therapy for rare pediatric immune disorder
Dr. Donald Kohn has been developing gene therapies for rare pediatric immune disorders for over 30 years.
Dr. Donald Kohn has been developing gene therapies for rare pediatric immune disorders for over 30 years.